# A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)

> **NCT02049281** · PHASE1 · TERMINATED · sponsor: **Endocyte** · enrollment: 3 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** Vintafolide

## Key facts

- **NCT ID:** NCT02049281
- **Lead sponsor:** Endocyte
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2015-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02049281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02049281, "A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02049281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*